Current Firm
8VC
Investments
9+ companies
Focus
Enterprise, Biotech
Kimmy Scotti is a founding partner at 8VC who combines deep operating experience as a serial entrepreneur since age 15 with venture investing, having built companies including ScriptRelief (acquired by UnitedHealth) and Fig.1 skincare alongside her investment work. She uses what she calls the 3 a.m. Principle for backing founders—only leading investments in founders she'd be excited to take calls from in the middle of the night—and positions herself as an unusually hands-on partner who sits in on customer service calls and works alongside founders on day-to-day challenges rather than staying in the boardroom.
Kimmy Scotti is a Founding Partner, 8VC at 8VC, based in Austin, TX.
Kimmy's investment focus spans Enterprise, Biotech, Digital Health, Aerospace & Defense, Space, primarily investing at the Pre-Seed, Seed, Series A, Series B+ stages. This specialization allows for deep domain knowledge and strong network effects that benefit portfolio companies.
Notable investments in Kimmy's portfolio include Anduril, Asana, Cityblock Health, Color, Ramp and 2 other companies. These companies reflect a pattern of backing high-potential startups across their focus sectors.
Kimmy Scotti is a Founding Partner, 8VC at 8VC, based in Austin, TX. Their investment focus includes Enterprise, Biotech, Digital Health.
Kimmy Scotti focuses on investments in Enterprise, Biotech, Digital Health, Aerospace & Defense, Space through 8VC. These focus areas reflect their domain expertise and the types of startups they actively seek to back.
Kimmy Scotti's notable portfolio investments include hims & hers, Vercel, Asana, Cityblock Health, Addepar. These companies span multiple sectors and stages, reflecting a track record of identifying high-potential startups.
Kimmy Scotti is currently at 8VC, headquartered in Austin, TX, serving as Founding Partner, 8VC.
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.